Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-20-004842
Filing Date
2020-02-26
Accepted
2020-02-26 17:15:52
Documents
3
Period of Report
2020-02-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k021320a1_aytubioscience.htm 8-K/A 27486
2 CONSENT OF HALL & COMPANY RELATING TO INNOVUS' FINANCIAL STATEMENTS f8k021320a1ex23-1_aytubio.htm EX-23.1 2592
3 GRAPHIC image_001.jpg GRAPHIC 8824
  Complete submission text file 0001213900-20-004842.txt   43640
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-38247 | Film No.: 20657104
SIC: 2834 Pharmaceutical Preparations